B. Matija Peterlin
- Molecular Biology top 0.5%
- Virology top 0.02%
- Immunology top 0.2%
- Infectious Diseases top 0.2%
- Epidemiology top 1%
- Co-authors
- David H. PriceKoh FujinagaPaul A. LuciwMatjaž BarboričKatherine A. JonesO. FacklerMatthias GeyerS. Kanazawa
- Topics
- HIV Research and Treatment (105 papers)Immune Cell Function and Interaction (50 papers)HIV/AIDS drug development and treatment (47 papers)
- Partner nations
- United StatesSloveniaGermany
In The Last Decade
B. Matija Peterlin
188 papers receiving 15.6k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Molecular Biology 8.3k
- Virology 7.8k
- Immunology 5.1k
- Infectious Diseases 3.6k
- Epidemiology 2.1k
Countries citing papers authored by B. Matija Peterlin
This map shows the geographic impact of B. Matija Peterlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Matija Peterlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Matija Peterlin more than expected).
Fields of papers citing papers by B. Matija Peterlin
This network shows the impact of papers produced by B. Matija Peterlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Matija Peterlin. The network helps show where B. Matija Peterlin may publish in the future.
Co-authorship network of co-authors of B. Matija Peterlin
This figure shows the co-authorship network connecting the top 25 collaborators of B. Matija Peterlin. A scholar is included among the top collaborators of B. Matija Peterlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Matija Peterlin. B. Matija Peterlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 70 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 7 | |
| 5 | 17 | |
| 6 | 17 | |
| 7 | 37 | |
| 8 | 154 | |
| 9 | 40 | |
| 10 | 122 | |
| 11 | Controlling the Elongation Phase of Transcription with P-TEFbbreakdown → | 874 |
| 12 | 41 | |
| 13 | 84 | |
| 14 | 71 | |
| 15 | 218 | |
| 16 | 145 | |
| 17 | 43 | |
| 18 | 22 | |
| 19 | 20 | |
| 20 | 3 |
About B. Matija Peterlin
B. Matija Peterlin is a scholar working on Virology, Immunology and Infectious Diseases, having authored 188 papers that have together received 15.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (105 papers), Immune Cell Function and Interaction (50 papers) and HIV/AIDS drug development and treatment (47 papers). The work is most often cited by research in Virology (7.8k citations), Immunology (5.1k citations) and Infectious Diseases (3.6k citations). B. Matija Peterlin has collaborated with scholars based in United States, Slovenia and Germany. Frequent co-authors include David H. Price, Koh Fujinaga, Paul A. Luciw, Matjaž Barborič, Katherine A. Jones, O. Fackler, Matthias Geyer, S. Kanazawa, Yong‐Hui Zheng and Ran Taube. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.